Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
67.75 HKD | +2.81% | +4.07% | +2.50% |
May. 03 | Swire Pacific Acquires Controlling Stake in Shanghai Healthcare Provider | MT |
Mar. 14 | Transcript : Swire Pacific Limited, 2023 Earnings Call, Mar 14, 2024 |
Summary
- According to Refinitiv, the company's ESG score for its industry is good.
Strengths
- The company returns high margins, thereby supporting business profitability.
- The company's attractive earnings multiples are brought to light by a P/E ratio at 10.11 for the current year.
- The company's share price in relation to its net book value makes it look relatively cheap.
- The company is one of the best yield companies with high dividend expectations.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- The company's earnings growth outlook lacks momentum and is a weakness.
- The group shows a rather high level of debt in proportion to its EBITDA.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Non-Alcoholic Beverages
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+2.50% | 11.3B | B+ | ||
+5.51% | 268B | B- | ||
+1.53% | 45.86B | B+ | ||
+21.81% | 23.48B | B- | ||
+39.34% | 17.71B | D | ||
-9.55% | 16.71B | B- | ||
+13.41% | 11.99B | A | ||
+10.37% | 10.37B | B+ | ||
-8.08% | 8B | - | D | |
+35.39% | 5.6B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- 19 Stock
- Ratings Swire Pacific Limited